Dr. Wallace E Duff , MD
Specialist • Omaha, NE
11704 W Center Rd Ste 210
Omaha, NE 681444327
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 1, 2005; this date does not establish years in practice.
-
Published CMS data list 41,746 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1010 — Injection, methylprednisolone acetate, 1 mg: 32,235 service units.
- J1100 — Injection, dexamethasone sodium phosphate, 1 mg: 3,444 service units.
- J1885 — Injection, ketorolac tromethamine, per 15 mg: 1,418 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 16 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 3,231 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Omeprazole — 562 prescription fills, including refills.
- Azithromycin — 435 prescription fills, including refills.
- Doxycycline Hyclate — 311 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 37 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: 4,881. Middle half: 356 to 7,687.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 8,979 in 2020 to 41,746 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
11704 W Center Rd Ste 210
Omaha, NE 681444327
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Nebraska College Of Medicine
1974
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
515 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $135,302 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $89,205 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,769 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$63,181 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,538.61 across 46 records.
By nature of payment
- Food and Beverage: $1,538.61 across 46 records.
Reporting-company totals (3 largest of 10)
- AstraZeneca Pharmaceuticals LP: $478.80 across 3 records.
- Phathom Pharmaceuticals, Inc.: $308.35 across 11 records.
- VERTEX PHARMACEUTICALS INCORPORATED: $188.21 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
52 years (graduated 1974)
CMS Doctors and Clinicians data list 1974 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Duff has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Duff as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Omaha and Nebraska
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: 4,881. Middle half: 356 to 7,687.
Too few clinicians listed under Specialist in Omaha have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
Close to the middle for clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: $135,302. Middle half: $30,620 to $249,572.
Too few clinicians listed under Specialist in Omaha have Medicare Part B data for 2024 to compare.
Paid by Medicare
Close to the middle for clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: $97,830. Middle half: $19,070 to $183,489.
Too few clinicians listed under Specialist in Omaha have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: 804. Middle half: 280 to 1,481.
Too few clinicians listed under Specialist in Omaha have Medicare Part D data for 2024 to compare.
Part D drug cost
Close to the middle for clinicians listed under Specialist in Nebraska (2024, 15 clinicians with data). Median for this group: $33,886. Middle half: $1,792 to $546,458.
Too few clinicians listed under Specialist in Omaha have Medicare Part D data for 2024 to compare.
81 active clinicians are listed under Specialist with a practice address in Omaha, NE (184 in Nebraska).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Omaha
0% of these 81 clinicians have the CMS telehealth indicator.
2.5% of these 81 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 365% from 8,979 in 2020 to 41,746 in 2024.
- 2020: 8,979
- 2021: 10,369
- 2022: 12,164
- 2023: 13,239
- 2024: 41,746
-
Medicare-allowed amount
Medicare-allowed amount varied from year to year: $138,986 in 2020 and $135,302 in 2024.
- 2020: $138,986
- 2021: $174,112
- 2022: $183,172
- 2023: $174,990
- 2024: $135,302
-
Paid by Medicare
Paid by Medicare varied from year to year: $96,556 in 2020 and $89,205 in 2024.
- 2020: $96,556
- 2021: $123,798
- 2022: $125,552
- 2023: $118,426
- 2024: $89,205
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 16% from 2,776 in 2020 to 3,231 in 2024.
- 2020: 2,776
- 2021: 2,924
- 2022: 3,102
- 2023: 3,126
- 2024: 3,231
-
30-day fills
30-day fills stayed about the same: 3,520 in 2020 and 3,769 in 2024.
- 2020: 3,520
- 2021: 3,623
- 2022: 3,713
- 2023: 3,752
- 2024: 3,769
-
Part D drug cost
Part D drug cost varied from year to year: $60,621 in 2020 and $63,181 in 2024.
- 2020: $60,621
- 2021: $66,021
- 2022: $84,701
- 2023: $110,422
- 2024: $63,181
-
Industry payments (Open Payments)
Industry payments (Open Payments) varied from year to year: $1,689.77 in 2021 and $1,538.61 in 2025.
- 2021: $1,689.77
- 2022: $1,560.51
- 2023: $767.49
- 2024: $952.42
- 2025: $1,538.61
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 46 records totaling $1,538.61.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $442.72 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $125.00 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $120.35 |
| Phathom Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
VOQUEZNA | General | $120.14 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $62.44 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $35.38 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $33.84 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.60 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.36 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $24.84 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $24.77 |
| ConvaTec Inc. |
Food and Beverage
In-kind items and services
|
INNOVAMATRIX AC | General | $24.40 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $23.47 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.42 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.21 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.21 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $22.05 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $21.98 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $21.92 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $21.67 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $21.60 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $21.16 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $20.74 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $20.51 |
| VERTEX PHARMACEUTICALS INCORPORATED |
Food and Beverage
In-kind items and services
|
— | General | $19.31 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1010
Injection, methylprednisolone acetate, 1 mg
|
32,235 | 182 | $1.25 | $0.13 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
3,444 | 251 | $15.00 | $0.11 |
|
J1885
Injection, ketorolac tromethamine, per 15 mg
|
1,418 | 190 | $20.00 | $0.65 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
1,347 | 202 | $50.00 | $0.46 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
1,098 | 474 | $275.00 | $78.25 |
|
J1030
Injection, methylprednisolone acetate, 40 mg
|
598 | 101 | $25.00 | $6.36 |
|
96372
Injection of drug or substance under skin or into muscle
|
591 | 315 | $100.00 | $12.31 |
|
95165
Professional service for preparation and provision of 1 or more antigens
|
441 | 14 | $40.00 | $12.23 |
|
69210
Removal of impacted ear wax
|
286 | 221 | $144.00 | $40.61 |
|
92504
Exam of ear using a microscope
|
88 | 64 | $120.00 | $24.41 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
50 | 50 | $343.50 | $94.62 |
|
92567
Test to assess middle ear function
|
48 | 48 | $62.00 | $14.18 |
|
70486
Ct scan of face without contrast
|
32 | 31 | $630.00 | $111.54 |
|
92553
Test for hearing various pitches using earphone and device placed against the bone
|
27 | 26 | $150.00 | $39.32 |
|
92557
Comprehensive hearing and speech recognition test
|
23 | 23 | $180.00 | $31.53 |
|
76380
Limited or follow-up ct scan
|
20 | 19 | $440.00 | $113.54 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Omeprazole | Omeprazole | 562 | 19,883 | $5,504.90 | 214 |
| Azithromycin | Azithromycin | 435 | 2,640 | $1,396.51 | 267 |
| Doxycycline Hyclate | Doxycycline Hyclate | 311 | 3,194 | $3,223.58 | 204 |
| Amoxicillin | Amoxicillin | 266 | 2,788 | $1,121.45 | 176 |
| Cefdinir | Cefdinir | 220 | 2,302 | $4,882.58 | 136 |
| Ipratropium Bromide | Ipratropium Bromide | 195 | 4,646 | $4,704.29 | 80 |
| Prednisone | Prednisone | 187 | 1,773 | $340.85 | 129 |
| Montelukast Sodium | Montelukast Sodium | 153 | 8,604 | $912.05 | 44 |
| Gabapentin | Gabapentin | 128 | 3,266 | $953.67 | 45 |
| Fluconazole | Fluconazole | 101 | 793 | $814.93 | 50 |
| Famotidine | Famotidine | 77 | 2,561 | $677.05 | 43 |
| Ofloxacin | Ofloxacin | 53 | 1,373 | $1,685.17 | 39 |
| Naproxen | Naproxen | 46 | 509 | $116.27 | 34 |
| Losartan Potassium | Losartan Potassium | 38 | 973 | $126.83 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 411 | $386.69 | 33 |
| Levofloxacin | Levofloxacin | 31 | 311 | $101.24 | 16 |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 29 | 639 | $1,077.67 | 18 |
| Alprazolam | Alprazolam | 26 | 566 | $124.05 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 273 | $129.01 | 20 |
| Pantoprazole Sodium | Pantoprazole Sodium | 25 | 1,580 | $184.01 | — |
| Fluocinonide | Fluocinonide | 23 | 430 | $727.89 | 22 |
| Clindamycin Hcl | Clindamycin Hcl | 23 | 236 | $270.75 | 20 |
| Clonazepam | Clonazepam | 21 | 630 | $266.43 | — |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 21 | 830 | $14,602.14 | — |
| Mupirocin | Mupirocin | 19 | 223 | $81.78 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-01-18NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
NUCC Taxonomy Code: 207Y00000X
An otolaryngologist-head and neck surgeon provides comprehensive medical and surgical care for patients with diseases and disorders that affect the ears, nose, throat, the respiratory and upper alimentary systems and related structures of the head and neck. An otolaryngologist diagnoses and provides medical and/or surgical therapy or prevention of diseases, allergies, neoplasms, deformities, disorders and/or injuries of the ears, nose, sinuses, throat, respiratory and upper alimentary systems, face, jaws and the other head and neck systems. Head and neck oncology, facial plastic and reconstructive surgery and the treatment of disorders of hearing and voice are fundamental areas of expertise.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OTOLARYNGOLOGY
I20080417000515
NE
4385722214
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 11704 W CENTER RD STE 210, OMAHA, NE 681444327 (Tel: 4023931454)
Registered at 11704 W CENTER RD STE 210, OMAHA, NE 681444327 (Tel: 4023931454)
Recorded as WALLACE DUFF, M.D.
Otolaryngology (license number reported to NPPES: NE 11860)
NPI status registered as active in NPPES database
Registered at 7710 MERCY RD, OMAHA, NE 681242372 (Tel: 4023931454)
Registered at 7710 MERCY RD, OMAHA, NE 681242346 (Tel: 4023931454)
Recorded as WALLACE DUFF,, M.D.
Specialist (license number reported to NPPES: NE 11860)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Specialists in Omaha
- Dr. Paul Nelson, MD
- Dr. Dennis Hayes, MD
- Dr. Allan Parungao, MD
- Dr. Mario Baccari, MD
- Dr. Mary Finnegan, MD
- Rick Wagelie, OTR, L
Mailing Address
11704 W Center Rd Ste 210
Omaha, NE 681444327
Phone: 4023931454